Although CCL5 promotes the recruitment of regulatory T cells (Tregs) into tumor site [62], we did not find any significant differences in Treg infiltration in the xenograft tissues between the four groups in the in vivo experiment. The gene discussed is CCL5; the disease is neoplasm.